Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review
Metabolic-associated fatty liver disease (MAFLD), previously known as non-alcoholic fatty liver disease, is a significant epidemiological problem and a well-known cardiovascular risk factor. The increasing number of cases creates the need for new therapeutic methods aimed at improving patient outcom...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2023-03-01
|
| Series: | Gastroenterology Review |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Effects-of-PCSK9-inhibitors-on-metabolic-associated-fatty-liver-disease-a-short-review,41,50394,1,1.html |